ChinaThe Pentagon delisted WuXi AppTec to comply with a court ruling.
The listing would have paved the way to a biotech company-of-concern designation.
WuXi argued the listing was arbitrary and capricious under the Administrative Procedure Act, and a US judge blocked it temporarily.
China hawks in Washington still see the contract drug developer as a rising national security threat.
How each outlet framed it
- STAT
- frames the delisting as compliance with a court ruling, with WuXi cast as a China-hawk threat and the designation as a biotech 'of concern' precursor
Sources: STAT